Yves Le Merrer

1.8k total citations
83 papers, 1.5k citations indexed

About

Yves Le Merrer is a scholar working on Organic Chemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, Yves Le Merrer has authored 83 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Organic Chemistry, 54 papers in Molecular Biology and 8 papers in Biochemistry. Recurrent topics in Yves Le Merrer's work include Carbohydrate Chemistry and Synthesis (47 papers), Chemical Synthesis and Analysis (25 papers) and Glycosylation and Glycoproteins Research (20 papers). Yves Le Merrer is often cited by papers focused on Carbohydrate Chemistry and Synthesis (47 papers), Chemical Synthesis and Analysis (25 papers) and Glycosylation and Glycoproteins Research (20 papers). Yves Le Merrer collaborates with scholars based in France, Switzerland and Slovenia. Yves Le Merrer's co-authors include Jean‐Claude Depezay, Christine Gravier‐Pelletier, Lydie Poitout, Marie-José Foglietti, Jacques Dumas, A. DUREAULT, Gildas Bertho, Isabelle McCort‐Tranchepain, Patricia Busca and Christine Greck and has published in prestigious journals such as Human Molecular Genetics, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Yves Le Merrer

81 papers receiving 1.5k citations

Peers

Countries citing papers authored by Yves Le Merrer

Since Specialization

Citations

This map shows the geographic impact of Yves Le Merrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Le Merrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Le Merrer more than expected).

Fields of papers citing papers by Yves Le Merrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Le Merrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Le Merrer. The network helps show where Yves Le Merrer may publish in the future.

Co-authorship network of co-authors of Yves Le Merrer

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Le Merrer. A scholar is included among the top collaborators of Yves Le Merrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Le Merrer. Yves Le Merrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and biological evaluation of a diazepanone-based library of liposidomycins analogs as MraY inhibitors 2011 ·European Journal of Medicinal Chemistry ·Janez Mravljak, (unknown), Bayan Al-Dabbagh, Muriel Crouvoisier, Ahmed Bouhss, Christine Gravier‐Pelletier, Yves Le Merrer	21
2	Synthesis and biological evaluation of potential new inhibitors of the bacterial transferase MraY with a β-ketophosphonate structure 2011 ·Organic & Biomolecular Chemistry ·(unknown), Rok Frlan, Bayan Al-Dabbagh, Ahmed Bouhss, Muriel Crouvoisier, Christine Gravier‐Pelletier, Yves Le Merrer	11
3	Synthesis of purin-2-yl and purin-6-yl-aminoglucitols as C-nucleosidic ATP mimics and biological evaluation as FGFR3 inhibitors 2011 ·European Journal of Medicinal Chemistry ·(unknown), Florent Barbault, François Maurel, Patricia Busca, Yves Le Merrer	8
4	A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model 2011 ·Human Molecular Genetics ·(unknown), Emilie Mugniery, Catherine Benoist-Lasselin, Nabil Kaci, Laurent Le Corre, Florent Barbault, Anne‐Lise Girard, Yves Le Merrer, Patricia Busca, Laurent Schibler, Arnold Münnich, Laurence Legeai‐Mallet	39
5	Bacterial transferase MraY inhibitors: Synthesis and biological evaluation 2010 ·Bioorganic & Medicinal Chemistry ·Delphine Lecerclé, (unknown), Bayan Al-Dabbagh, Muriel Crouvoisier, Ahmed Bouhss, Christine Gravier‐Pelletier, Yves Le Merrer	20
6	Synthesis and biological evaluation of a triazole-based library of pyrido[2,3-d]pyrimidines as FGFR3 tyrosine kinase inhibitors 2010 ·Organic & Biomolecular Chemistry ·Laurent Le Corre, Anne‐Lise Girard, (unknown), François Radvanyi, Catherine Benoist-Lasselin, (unknown), Emilie Mugniery, Laurence Legeai‐Mallet, Patricia Busca, Yves Le Merrer	49
7	Towards New MraY Inhibitors: A Serine Template for Uracil and 5‐Amino‐5‐deoxyribosyl Scaffolding 2007 ·European Journal of Organic Chemistry ·Laurent Le Corre, Christine Gravier‐Pelletier, Yves Le Merrer	10
8	Chemical investigations in the synthesis of O-serinyl aminoribosides 2006 ·Tetrahedron Asymmetry ·(unknown), Christine Gravier‐Pelletier, Yves Le Merrer	29
9	Synthesis and glycosidase inhibitory activity of new hexa-substituted C8-glycomimetics 2005 ·Beilstein Journal of Organic Chemistry ·(unknown), Christine Gravier‐Pelletier, Gildas Bertho, T. Prangé, Yves Le Merrer	15
10	Synthesis of Peptidomimics Through Sugar-Based Scaffolds 2003 ·Humana Press eBooks ·Yves Le Merrer, Lydie Poitout, Jean‐Claude Depezay	0
11	A Straightforward Route to Indolizidine and Quinolizidine Analogues as New Potential Antidiabetics. 2003 ·ChemInform ·Christine Gravier‐Pelletier, (unknown), Yves Le Merrer	2
12	A versatile scaffold for a library of liposidomycins analogues: a crucial and potent glycosylation step 2003 ·Tetrahedron Asymmetry ·Christine Gravier‐Pelletier, (unknown), Yves Le Merrer	13
13	Efficient route to optically pure polyfunctionalized cyclooctanes 2002 ·Tetrahedron Letters ·Christine Gravier‐Pelletier, (unknown), Yves Le Merrer	18
14	Synthesis of C2-symmetric guanidino-sugars as potent inhibitors of glycosidases 2000 ·Bioorganic & Medicinal Chemistry ·Yves Le Merrer, (unknown), Christine Gravier‐Pelletier, Jean‐Claude Depezay	35
15	Synthesis of azasugars as potent inhibitors of glycosidases 1997 ·Bioorganic & Medicinal Chemistry ·Yves Le Merrer, Lydie Poitout, Jean‐Claude Depezay, (unknown), (unknown), Marie-José Foglietti	103
16	Synthesis of azasugars. Part 2 isomerization of polyhydroxylated azepanes 1996 ·Tetrahedron Letters ·Lydie Poitout, Yves Le Merrer, Jean‐Claude Depezay	24
17	Enantiopure aminotriol from d-isoascorbic acid synthesis of 1996 ·Tetrahedron Asymmetry ·(unknown), (unknown), Yves Le Merrer, Jean‐Claude Depezay	20
18	Lipoxins A4 and B4 Total Synthesis Including Deprotection Studies 1992 ·Tetrahedron ·Christine Gravier‐Pelletier, Jacques Dumas, Yves Le Merrer, Jean‐Claude Depezay	11
19	Chiral α-hydroxy- and α,β-dihydroxy- aldehydes from D-isoascorbic and L-ascorbic acids. Useful precursors for the synthesis of fatty acid metabolites. 1990 ·Tetrahedron Letters ·Yves Le Merrer, Christine Gravier‐Pelletier, Jacques Dumas, Jean‐Claude Depezay	24
20	Synthesis of Diepoxides and Diaziridines, Precursors of Enantiomerically Pure a-Hydroxy and a-Amino Aldehydes or Acids, from D-Mannitol 1987 ·Heterocycles ·Jean‐Claude Depezay, Yves Le Merrer, (unknown), Christine Greck, (unknown), Christine Gravier‐Pelletier	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact